SCHEMBL396132

SCHEMBL396132

Cc1cc(C)c(O)c(C(C)(C)C)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.45
CYP2C19 P33261 4/20 0.45
CYP1A2 P05177 3/20 0.45
CA2 P00918 3/20 0.40
CA1 P00915 2/20 0.40
GABRA1 P14867 2/20 0.40
GABRB2 P47870 2/20 0.40
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
POLB P06746 1/20 0.39
TYR P14679 1/20 0.39
ESR1 P03372 2/20 0.37
ESR2 Q92731 1/20 0.37
HIF1A Q16665 3/20 0.35
CYP2D6 P10635 2/20 0.35
HSD17B10 Q99714 1/20 0.35
PTGS1 P23219 4/20 0.33
PTGS2 P35354 4/20 0.33
ALOX5 P09917 3/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785191 0.84 CYP2C9 (0.43) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL31424079 0.82 CYP2C19 (0.52) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL1476812 0.82 CYP2C19 (0.52) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL392804 0.82 SMN1; SMN2 (0.52) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL30448978 0.82 SMN1; SMN2 (0.52) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL9248531 0.81 CYP2C9 (0.45) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL392594 0.81 CYP2C9 (0.40) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL13941218 0.79 HSPA5 (0.48) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL395067 0.77 CYP2C9 (0.44) CYP2C9CYP2C19CYP1A2CA2CA1
SCHEMBL8647268 0.77 ALDH1A1 (0.35) CYP2C9CYP2C19CYP1A2CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112724302-B Ethylene-alpha-olefin copolymer, process for producing the same, ethylene resin composition, and film 住友化学株式会社 2023-10-31 CN disclosed
US-11643533-B2 Film, method of producing film, and bag SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-09 US disclosed
CN-110352213-B Film 住友化学株式会社 2022-09-09 CN disclosed
US-11149102-B2 Film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-10-19 US disclosed
US-20210284829-A1 FILM, METHOD OF PRODUCING FILM, AND BAG SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-09-16 US disclosed
EP-3878896-A1 FILM, METHOD OF PRODUCING FILM, AND BAG SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2021-09-15 EP disclosed
CN-113387055-A Film, method for producing film, and bag 住友化学株式会社 2021-09-14 CN disclosed
EP-3816198-A1 ETHYLENE-ALPHA-OLEFIN COPOLYMER, METHOD OF PRODUCING ETHYLENE-ALPHA-OLEFIN COPOLYMER, ETHYLENE-BASED RESIN COMPOSITION, AND FILM SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2021-05-05 EP disclosed
CN-112724302-A Ethylene-alpha-olefin copolymer, process for producing the same, ethylene resin composition, and film 住友化学株式会社 2021-04-30 CN disclosed
US-20210122854-A1 ETHYLENE-alpha-OLEFIN COPOLYMER, METHOD OF PRODUCING ETHYLENE-alpha-OLEFIN COPOLYMER, ETHYLENE-BASED RESIN COMPOSITION, AND FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-04-29 US disclosed
US-20030069127-A1 Modified particle,support, catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMTED (JP) 2003-04-10 US disclosed
EP-1300425-A2 Catalyst component for addition polymerization, process for producing said catalyst and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-04-09 EP disclosed
US-20030060579-A1 Catalyst component for addition polymerization, process for producing catalyst for addition polymerization and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-27 US disclosed
EP-1275662-A1 MODIFIED PARTICLE, SUPPORT, CATALYST COMPONENT FOR ADDITION POLYMERIZATION, CATALYST FOR ADDITION POLYMERIZATION, AND PROCESS FOR PRODUCING ADDITION POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-01-15 EP disclosed
US-20020143124-A1 Homogeneous type solid catalyst component or homogeneous type solid catalyst, process for production thereof and process for producing addition polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-10-03 US disclosed
US-20020013433-A1 Transition metal compound, catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-31 US disclosed
US-20010053832-A1 Olefin polymerization catalyst and process for producing olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-12-20 US disclosed
EP-1153938-A1 CATALYST FOR STEREOREGULAR POLYMERIZATION OF ALPHA-OLEFIN AND PROCESS FOR PRODUCING STEREOREGULAR ALPHA-OLEFIN POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-11-14 EP disclosed
EP-1134234-A1 Olefin polymerization catalyst and process for producing olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-09-19 EP disclosed
EP-1081167-A1 Olefin polymerization catalyst and process for producing olefin polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013433-A1 Transition metal compound, catalyst for addition polymerization, and process for producing addition polymer ASH2L, ARL1, AS3MT CYP2C9 3953/4885CYP2C19 3745/4885CYP1A2 3606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.